You need to be logged in to view this video

Genprex is reprogramming the course of cancer and diabetes. Genprex’s CEO, Rodney Varner, will provide an investor presentation with an overview of company highlights, recent milestones, and clinical updates for its oncology and auto-immune disease programs.
Rodney Varner
Duration: 32:55